Cian Healthcare IPO vs Par Drugs IPO

Comparison between Cian Healthcare IPO and Par Drugs IPO.

IPO Details

Cian Healthcare IPO is a SME Fixed Price IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Cian Healthcare IPO is up to ₹35.99 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Cian Healthcare IPO is ₹61.00 per share and of Par Drugs IPO is ₹51.00 per share.

 Cian Healthcare IPOPar Drugs IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹59.00 per share
Issue Price (Upper)₹65.00 per share
Issue Price (Final)₹61.00 per share₹51.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size2000 shares2000 shares
Fresh Issue Size59,00,000 shares15,88,000 shares
Fresh Issue Size (Amount)up to ₹35.99 Crup to ₹8.10 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total59,00,000 shares15,88,000 shares
Issue Size Total (Amount)up to ₹35.99 Crup to ₹8.10 Cr

IPO Timetable

Cian Healthcare IPO opens on May 02, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Cian Healthcare IPO and Par Drugs IPO is May 15, 2019, and May 08, 2019, respectively.

 Cian Healthcare IPOPar Drugs IPO
Issue OpenMay 02, 2019May 03, 2019
Issue CloseMay 15, 2019May 08, 2019
Basis Of Allotment (Tentative)May 20, 2019May 13, 2019
Initiation of Refunds (Tentative)May 21, 2019May 14, 2019
Credit of Share (Tentative)May 22, 2019May 15, 2019
Listing date (Tentative)May 23, 2019May 16, 2019

Financials & KPIs

Cian Healthcare IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .

 Cian Healthcare IPOPar Drugs IPO
Financials

Company Financials (Restated)

Period Ended31 Dec 201831 Mar 201831 Mar 201731 Mar 2016
Assets85.9077.6261.2856.82
Total Income44.4859.5951.8547.16
Profit After Tax5.253.762.241.37
NET Worth25.3616.8013.0410.81
Reserves and Surplus8.2115.4011.649.41
Total Borrowing43.3747.6439.6831.06
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets51.3653.9456.04
Total Income46.4142.4248.81
Profit After Tax2.421.501.85
EBITDA5.288.028.50
NET Worth29.1220.7019.20
Reserves and Surplus24.6412.2510.75
Total Borrowing11.5823.1324.81
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)96.6%99.55%
Promoter Shareholding (Post-Issue)97.09%72.5%
Market Cap₹142.50 Cr.₹31.38 Cr.

Shares Offered

In the Cian Healthcare IPO Retail Individual Investors (RII) are offered 29,50,000 shares while in Par Drugs IPO retail investors are offered 29,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Cian Healthcare IPO and in Par Drugs IPO.

 Cian Healthcare IPOPar Drugs IPO
Market Maker Reservation3,16,000 shares84,000 shares
NII29,50,000 shares7,78,000 shares
RII29,50,000 shares7,80,000 shares
Employee30,000 shares
Total59,00,000 shares15,88,000 shares

Bids Received (Subscription)

Cian Healthcare IPO subscribed 1.25x in total, whereas Par Drugs IPO subscribed 5.64x.

 Cian Healthcare IPOPar Drugs IPO
NII (times)1.91x3.48x
RII (times)0.59x7.97x
Employee (times)1.00x
Total (times)1.25x5.64x

Compare with others

Compare:

Cian Healthcare IPO Vs Par Drugs IPO